Wednesday, 27 December 2017

Contactless Payments Market Expected to Reach $25,565 Million by 2023

Contactless Payments Market by Device Type and Industry Vertical: Global Opportunity Analysis and Industry Forecast, 2017-2023, the global contactless payments market was valued at $6,734 million in 2016, and is projected to reach at $25,565 million by 2023, growing at a CAGR of 21.2% from 2017 to 2023. In 2016, the mobile devices segment accounted for the highest revenue share in the contactless payments market.

Consumers as well as enterprises have increasingly adopted number of ways for convenient and secure payments. One of such medium is a contactless system that has revolutionized the retail and transportation industries in the past few years.

Get the PDF brochure of this market insight:

The global contactless payments market is driven by convenience in processing low-value payments, increased revenue opportunities, and reduced transaction time. However, high costs involved for the deployment of EPOS terminals and lack of trust and security concerns hamper the market growth.

Europe dominated the global market in 2016, and is expected to continue this trend during the forecast period, owing to the growing adoption of contactless smart cards. Furthermore, Asia-Pacific is expected to grow at the highest CAGR during the forecast period.

In 2016, the global market was dominated by the BFSI industry, and is expected to continue this trend during the forecast period. However, the others segment is expected to witness the highest growth, owing to increase in installation of contactless readers in the premises of hospitals for convenience of both patients and doctors.

 Key Findings of the Contactless Payments Market:
  •        The mobile devices segment is expected to exhibit significant increase in the global contactless payments market during the forecast period.
  •        In 2016, the BFSI segment accounted for the highest revenue among the other industry verticals.
  •        Asia-Pacific is anticipated to exhibit substantial growth during the forecast period.

The key players profiled in the report include Ingenico Group, Verifone Systems, Inc., Inside Secure, on Track Innovations, Oberthur Technologies SA, Proxama, PLC., Wirecard AG, Giesecke & Devrient GmbH, Gemalto N.V., and Heartland Payment Systems, Inc.

Research on Wood Plastic Composites Market, Growth & Development

Global Wood Plastic Composites (WPC) Market was valued at $2,551 million in 2016, and is expected to reach at $6,584 million by 2023, registering a CAGR of 12.6% from 2017 to 2023. Asia-Pacific is expected to dominate the market, both in terms of volume and value, and is expected to maintain this trend throughout the forecast period.

WPCs are composed of wood or wood flour, plastics, and additives. The source of the materials can be either virgin or recycled material. The demand for materials based on renewable raw materials has risen steadily in the recent years. Furthermore, increase in interest from governments about climate protection and sustainability results in expansion of market size of natural-based materials such as wood plastic composites (WPC).
WPC provides a challenge to solid wood/polymer products as alternative construction materials and is expected to increase on a large scale in the near future due to development of more recycled products. Furthermore, reliable and consistent recyclable material supply chains are required for strong market growth, though high demand from automotive sector is expected to augment the market growth.
The building & construction segment accounted for more than three-fourths share of the global market in 2016, in terms of volume, and is expected to maintain its dominance during the forecast period, owing to its improved performance and appearance characteristics. However, automotive components are also expected to grow with a high rate due to rise in demand for recyclable and lightweight materials.

Key Findings of the Wood Plastic Composites Market:
  • In terms of value, the building & construction segment is expected to grow at a CAGR of 12.6% during the forecast period.
  • In Asia-Pacific, China is estimated to grow at the highest CAGR of 12.9%, in terms of value.
  • PVC-based composites occupied around one-eighth of the global market share in 2016, in terms of volume.
  • U.S. accounted for over one-fifth of the global market in 2016, and is expected to grow at a significant CAGR of 8.8%, in terms of volume.
The major companies profiled in the report include, Advanced Environmental Recycling Technologies, Inc., Axion International, Inc., Beologic N.V., Certainteed Corporation, Fiberon, LLC., Fkur Kunststoff GmbH, Polymera, Inc., Tamko Building Products, Inc., Timbertech Ltd., and Trex Company, Inc.

Tuesday, 26 December 2017

Growing Trends and Developments in the Ultra-Secure Smartphone Technology in Future

Ultra-Secure Smartphone Market by Operating System and End User: Global Opportunity Analysis and Industry Forecast, 2017-2023, the global ultra-secure smartphone market was valued at $818 million in 2016, and is projected to reach $3,191 million by 2023, growing at a CAGR of 21.6% from 2017 to 2023. In 2016, the android segment accounted for the highest revenue share in the ultra-secure smartphone market.

Rise in customers inclination toward ultra-secure smartphones, its ability to provide better security and reliable transmission of data, and growth in adoption of ultra-secure smartphones for military and commercial applications drive the global ultra-secure smartphone market growth. However, requirement of cooperating handsets and its high price hampers this growth to a certain extent.

Android segment is expected to grow at a highest CAGR of 21.70% due to increase in the integrity of the android operating system along with its ability to run on all mobile devices.

Android segment dominated the global ultra-secure smartphone market in 2016, and is expected to remain dominant during the forecast period, owing to the rapid adoption of android in many ultra-secure smartphones. Furthermore, it is expected to grow at the highest CAGR of 21.70% during the forecast period.

North America accounted for the highest revenue in 2016. Further, Europe is anticipated to witness the fastest growth rate during the forecast period.

Key Findings of the Ultra-Secure Smartphone Market:
  • The android segment is expected to exhibit significant growth in the global ultra-secure smartphone market during the forecast period.
  • In 2016, the government agencies segment accounted for the highest revenue among the other end users.
  • North America generated the highest revenue in 2016.
  • Europe is anticipated to exhibit substantial growth during the forecast period.

Some of the key players operating in the ultra-secure smartphone market that are profiled in the report include ESD Crytophone, BlackBerry Limited, DarkMatter, Inc., Sirin Labs, Turing Robotic Industries, Boeing, Silent Circle, LLC, and Atos SE.

Tuesday, 6 September 2016

New Two-step Turbocharger to Improve Performance and Reduce Lag

Fuel-efficient turbochargers with low emission levels are in demand as environment safety is a growing concern.

Environment awareness and price of fossil fuels will play an important role in development of next generation engines. Organizations are expected to maintain low levels of CO2 emissions so as to reduce fuel consumption. Thus, R&D activities are in full swing to develop environment friendly engines and turbochargers. Multiple organizations worldwide are coming together to come up with a product, which is fuel efficient as well as reliable in its functionality. Companies are investing time and resources to assure the production of top quality turbochargers. The volume of vehicle production has grown exponentially in the last decade, which has boosted the demand for turbochargers worldwide. Allied Market Research has recently published a report which gives useful information related to the industry such as market size, share, and growth. Customers are making a conscious effort to purchase vehicles and engines that comply with environment safety regulations.

Turbocharger technology developed to increase efficiency of 2-stroke and 4-stroke engines

It has become important for organizations to address environmental issues and assure that harmful emissions are kept at minimum levels. Development activities now focus on efficient fuel consumption values along with reduction of harmful emissions without excess fuel consumption. 

In August 2016, MAN D&T Business Unit Turbocharger discussed the present development activities in the field of combustion of air supply. The company introduced its advanced turbocharger technology that enhances efficiency of huge 2-stroke and 4-stroke gas and diesel engines.  The technology does not only concentrate on efficiency but also helps to reduce nitrogen oxide emissions. Daniel Albrecht , Project Manager quoted, “The combination of a MAN TCR20, for the low-pressure stage, and an MAN TCX17, for the high-pressure stage, offers significant potential for today’s demand for more economical and environmentally-friendly engine operation.” 

The new MAN ECOCHARGE Two-Stage Turbocharging System offers huge benefits to customers and engine builders. Compared to single-stage turbochargers, the new technology increases turbocharging efficiency. This is due to the position of the intercooler that is placed between low pressure-stage and high pressure-stage turbochargers. This reduces the energy that is required to restrict the intake air to high pressure. The tests depict that as much as 8% fuel can be saved. The ECOCHARGE system has been designed for gas as well as HFO-burning engines. 

Turbocharger firm acquired to expand product category

The demand for new technology and products are pushing organizations to join hands and offer a wide range of services and products. 

In August 2016, Motorcar Parts of America announced the acquisition of ZOR Industries. With this move, the company is set to expand its product line with the introduction of in-house developed brake power boosters and turbochargers. Selwyn Joffe, chairman, president and chief executive officer of Motorcar America said, “The launch of brake power boosters follows a similar strategic approach to our previous product line introductions, namely working with an existing customer that is committed to our program and supportive of the wide-range of value-added services that enhance the product category." The move will also provide Motorcar Parts of America a customer base along with present technology. 

New patent for a two-stage turbocharger

Engineers are putting in a lot of effort to improve the performance of turbochargers. Although the modern turbochargers are developed using advanced technology, there is a wide scope for improvement. A traditional two-stage turbocharger is designed to enable turbines to operate concurrently at low and mid-engine speeds. Low-pressure turbines function at high speeds. The setup can’t accommodate low or high pressure side that results in low-end performance. 

The new two-stage turbocharger setup introduced by General Motor will address the issues mentioned above by connecting the high-pressure turbo to the exhaust via a high pressure inlet duct. Depending on the engine load and speed, ECU pilots the actuator to isolate one of the two turbos. This setup increases the performance and reduces lag. It is still unknown when the technology will feature in the vehicles manufactured by General Motors, but the company hopes to use it in premium vehicles before using it in all other vehicles.

Turbocharger market to expand in Asia

The turbocharger market is set to expand in Asia. China is dominating the market in the region as demand for vehicles has increased. The number of turbochargers installed in the country are also growing every year. The business environment and the general infrastructure to manufacture turbochargers in China is favorable compared to some of other countries in the region. 

Tuesday, 23 August 2016

Regenerative Medicines: A Potential Game Changer in the Medical Field

Regenerative medicines offer a wide range of medical opportunities; Improve bone development and healing, aid in severe muscle injuries as well as show traces of muscle regeneration

Regenerative Medicine is considered to be a revolution in the medical field. Technology has taken huge strides forward and come a long way. Medical science has embraced reliable and effective methods that have generated positive results. Robin Smith, CEO and co-founder of ORIG3N, a regenerative medical company, compares the regenerative medicine to the internet in 1993. 

According to him, this could be the next big thing in the medical field. The current regulations do not need a massive tweak to produce cost-effective drugs. Several organizations and industry players seek new pathways to expand their business and growth. Allied Market Research, explores the various aspects of the market in a report, ‘Regenerative Medicine Market’ such as market growth, share, and size. The industry is staring at a bright future as it’s a revolution in the medical industry.

Plasma makes an entry in regenerative medicine market 
Plasma, which is found in sun, stars, TVs, neon signs, and fluorescent light has made its way in the regenerative medicine stream. Traditionally used in the agriculture and in space propulsion industry, plasma is now being utilized in the medical field as well. A team of scientists have explained how plasma can be used to improve bone development in the research titled ‘Journal of Tissue Engineering and Regenerative Medicine’. The scientists believe that this is a major breakthrough and a promising factor as far as bone healing and development is concerned. Cold plasma is modified to make a positive impact on bone formation and structuring of the cartilage by revamping the matrix. The study revealed how microsecond pulsed cold plasma had a positive impact on bone development

Dr. Freeman said “As research into medical application of cold plasma expands, it will be important to study various plasma types and conditions in tissue models, rather than isolated cells. Because cold plasma affects each cell type and matrix protein to produce variable physiological effects, it’s important to study not just how each cell behaves when exposed, but also how they react together within the tissue and organismal environment.”

Extra cellular matrix (ECM) derived from pig tissue used to treat patients a big hit
The generic treatment procedures did not have a huge impact on the patients suffering from muscle injuries and other muscle related problems. Researchers at the University of Pittsburgh School of Medicine and McGowan Institute for Regenerative Medicine reveal that there was a commendable improvement in strength and motion of patients suffering from a medical condition being treated with regenerative medicines. There was a hint of skeletal regeneration of muscle as well, which boosted their confidence to use the extracellular matrix (ECM), which is derived from pig tissue. This new medical revelation holds a lot of promise and could soon eliminate the current practices. Stephen F Badylak, Ph.D., professor of surgery at Pitt and deputy director of McGowan Institute quoted “This approach could be a game changer and not just an incremental advance. Previously, there was no effective treatment for these patients, but this approach holds significant promise.”

Patients, who were surgically implanted with bioscaffolds from pig tissue, showed 37.3 percent strength improvement and 27.1 percent improvement in the range of motion tasks. CT/MRI scans also revealed soft improved soft tissue formation in all the 13 patients who were treated. Damaged leg muscles of patients grew stronger and were depicting traces of regeneration in three out of five patients. 

Bright future of Regenerative Medicines is changing the competitive landscape of the market
Regenerative medicines are redefining medical technology. Top manufacturers of the world are coming together and forming partnerships to improve and strengthen their foothold in the industry. It is not always feasible for one organization to procure every technology at its disposable. Looking at this situation the regenerative medicine market has started to witness acquisitions and partnerships that reduce the operation costs. 

An Irish pharmaceutical company, Mallinckrodt recently invested to acquire U.S. based regenerative medicine company, Stratatech. As a result of this deal, Mallinckrodt will now be able to focus on their pipeline products with off-the-shelf alternative known as StrataGraft. It is currently in the third phase of testing for partial thickness burns. Throwing a light on the acquisition, chief executive of Mallinckrodt, Mark Trudeau reveals that this move will give the company a stage or a platform to concentrate on the development of cell-based therapies which can be used for the treatment of a wide range of wounds. Mallinckrodt have made a series of acquisitions hoping to become a pharma specialist. 

The company signed two deals in 2015, a $1.3 billion deal to acquire immune cell therapy specialist Therakos and $2.3 billion to buy hospital treatment company Ikaria.

BioTime, Inc. recently made an announcement regarding the issuance of 31 new patents owned or licensed by the company. There are 700 issued and pending patents worldwide and the new patents will add to the number. The issue of these new patents will strengthen the IP position in the regenerative medicine field of the company and other firms affiliated to it. The company also aims to protect its core products keeping an eye on the current and future development prospects and attract new partnerships for product development.

Regenerative medicines are here to stay as research activities are on the rise
Regenerative Medicines are surely a game changer and the medical industry has accepted them with open arms. The use of these medicines have given positive results worldwide and has gained a lot of popularity in last decade. U.S. and Europe are frontrunners in this field as they are technologically sounder than the other regions of the world. The world regenerative market is projected to reach $30,237 million by 2022 according to the report published by Allied Market Research. 

The industry and the market is driven by various factors such as technological advancements in tissue and organ regeneration, increasing rate of chronic diseases, growing popularity of nanotechnology, and the stem cell technology. Another factor that could boost the growth of the market is the increasing number of degenerative diseases and lack of organs that can be used for transplantation. New research conducted by scientists and researchers also help in market growth. New avenues and pockets are being explored every day and supplements the growth of the market as well. Keeping in mind all the factors mentioned, it is safe to say that the regenerative medicine industry is here to stay.

Thursday, 18 August 2016

Automotive Interiors: Significant Aspects Influencing Buying Decision

Suppliers and manufacturers focus on offering enhanced overall driving experience by building superior interiors with technological innovation, collaborations, and R&D activities.

 Designed by Freepik

Buying decision of a vehicle is not influenced only by fuel efficiency anymore. It has exceeded the expectations of customers to have a comfortable overall driving experience. So, automakers have to take necessary measures to ensure that they are meeting customer demands and offering the best services at optimal prices. Though it presents challenges to manufacturers, technological advancements and increased focus on R&D activities have enabled them to incorporate changes in design of interiors to provide enhanced experience. Automotive interiors are systems and components designed for providing comfort, sound insulation, and convenience to users. Automakers are developing superior products with an introduction of innovative features that are capable of delivering a better overall experience. In its recent report on the automotive interiors market, Allied Market Research states that the market is expected to garner a revenue of $200 billion by 2022, registering a CAGR of 6.5% from 2016 to 2022. Technological innovation, recent market trends, future scope, and competitive intelligence are outlined in the report.

Axalta and United Paint’s combined expertise to build superior interiors: 

Manufacturers are acquiring other companies to produce better products by combining expertise of both companies. Axalta Coating Systems, a leading liquid and powder coatings supplier, has acquired the automotive interior rigid thermoplastics coatings division of United Paint & Chemical Corporation. Axalta, headquartered at Philadelphia, U.S. offers innovative and sustainable coating solutions. The acquisition of United Paint will help Axalta to improve durability and aesthetic qualities of automotive components. United Paint, a Michigan-based company founded in 1953 is offering coating solutions for vehicle interior applications. 

Steven R. Markevich, Executive Vice President and President of Transportation Coatings and Greater China of Axalta said, “United Paint’s interior rigid thermoplastics coating technology is a great fit for Axalta as we fulfill our commitment to provide our customers in the global vehicle manufacturing industry with a complete range of coating systems.” He added that there is a demand for lighter alternatives for traditional materials, so vehicle interiors are a logical extension of the expertise they have developed to serve the growing automotive plastic components market. Vehicle manufacturers will benefit by relying on Axalta as a single source supplier of coatings for vehicle interiors as well as exterior surfaces. This acquisition will help auto manufacturers to maximize their potential and gain competitive advantage in global market by implementing solutions developed by combined expertise.

The biggest Automotive Interiors Expo to take place next year:

Interior material suppliers and auto manufacturers must be updated about recent trends and developments. In a rapidly changing world and advancements in technology, they will be benefited from the biggest interiors expo set to take place in 2017. Automotive Interiors Expo will take place on 20–22 June in Stuttgart, Germany. Car interiors of manufacturers ranging from Ferrari, Porsche to GM, Toyota, and others will be displayed at the show. Latest developments in the industry such as plastic compounding & master-batching, metalized plastics, and chrome-look plastics will be showcased. In addition, exhibition of wide range of fabrics, shape-forming materials, acoustical materials, adhesive systems, and lighting will help in bringing innovation in products. This show will help suppliers and interior design teams of manufacturers by offering a wide array of products that will help them innovate and fulfill expectations of customers. 

DuPont’s Hydrel RS to improve airbags systems:

Sustainability has become a prime focus of suppliers for developing interior parts. Taking this into consideration, DuPont collaborated with Takata-Petri to develop the thermoplastic elastomer, Hydrel RS produced from renewable materials. The materials used for producing this thermoplastic elastomer are derived from non-food biomass. Hydrel RS, containing at least 35% of renewable content by weight can be used in airbag systems. This product has technical properties that offer consistent physical properties over different temperature ranges. For more than last 15 years, DuPont and Takata-Petri are manufacturing innovative safety systems that can be used in driver and passenger airbags. 

Hydrel RS is based on a thermoplastic ether-ester elastomer (TPC-ET) having hard segments and soft segments. Hard segments contain a polybutylene terephthalate, while soft segments contain a polyether, which is derived from non-food biomass. In its finished, compounded form, Hydrel RS can be as used in airbag systems. The development team at DuPont demonstrated that the performance of Hytrel RS is superior in terms of use of renewable energy and greenhouse gas emissions as compared to a petroleum-based TPC-ET.

Less noisy interiors:

Suppliers are implementing various technologies in their products to help manufacturers make interiors less noisy. International Automotive Components, an automotive interiors supplier based in Luxembourg is focusing on production of injection-molded, lightweight inner-dash insulated dashboard that offers superior interior acoustical performance. The company has announced that its Prestice facility in Czech Republic has started production of such dashboards for two manufacturers from Europe. 

The traditional process of production of acoustic parts involve molding of thermoplastic-based heavy layer sheet under vacuum. “This process in itself has limitations,” an IAC spokesperson told WardsAuto. “The thickness of the part is nearly uniform and detailed and precise part geometry is difficult to reproduce.” On the other hand, injection-molded process involves production of parts that are heavier where more insulation is needed and thinner in other areas. “By doing this IAC can optimize the acoustic performance and at the same time reduce the weight of the component,” the spokesperson added. 

The improvement of acoustic properties through molding process offers reliable distribution for designing and production of perfectly fit components for dashboards. So, this material is beneficial for manufacturers as it provides freedom to design the entire dashboard module as per their design considerations. The spokesperson claimed that they are aiming to produce a dashboard that weighs 40% less than conventional dashboards that are formed under vacuum. Furthermore, this insulation technology complements its range of innovative lightweight acoustical insulation products, such as sprayed-polyurethane-dash inner technology. This technology reduces weight by 20% and superior acoustic performance as compared to traditional technologies. Various technologies are emerging that help in reduction of noise from dashboard enabling comfortable and enhanced driving experience.

Tuesday, 16 August 2016

Liver Disease Treatment Market Grows as Unhealthy Lifestyle Patterns Dominate

Changing lifestyle patterns and unhealthy food habits are pushing researchers to develop new medical solutions to treat liver diseases.

Modern times have seen a significant change in lifestyle and general habits of human beings. Increasing alcohol consumption, unregulated diet patterns, and ignorance towards other minute health problems have all added to the condition. These factors are the major reasons why the number of liver diseases have increased worldwide. Likewise, ageing population that is vulnerable to various medical conditions also contribute to the liver disease treatment market. Eyeing this sudden rise in the number of patients with liver disease is Allied Market Research. This market research firm has published a report titled “Liver Disease Treatment Market.” The study explores the various aspects of the industry such as market share, size, and growth.  

Non Alcoholic Fatty Liver Disease (NAFLD) on the rise in developed nations

NAFLD is on the rise in the developed nations with number of people indulging in junk food growing each day. Indulgence in such food items has made obesity a genuine problem amongst the masses in regions including North America and Europe. Unhealthy diet, wayward lifestyle and high stress levels have led to an increase of NAFLD not only in the United States but also United Kingdom. Digestive Disease Week (DDW) 2016 highlighted that there have been significant advances in clinical practice hepatology to treat liver diseases. This disclosure was in reference to a research presented at the event. 

Ray of light in liver disease treatment: NAFLD & Liver Fibrosis

There has been significant research on the biology of the fatty liver disease to understand how the disease infects the organ, why does it occur and also how it can be dealt with without any side effects. Researchers at the Perelman School of Medicine at the University of Pennsylvania have made a progress in this direction. They have studied and analyzed the reports that help them understand the situation better. The exchange between two cell nucleus proteins lead to separate as well as symbiotic lives has helped the research team at the Penn state university to gauge the fatty liver disease. Fatty liver is the main cause of liver failure in the United States. Mitchell Lazar, MD PhD, director of the Institute Diabetes, Obesity, and Metabolism said, “We showed that simply deleting the protein HNF6 in liver cells of adult transgenic mice fed normal laboratory chow leads to fatty liver syndrome.” The research team at the Perelman School of Medicine have done a commendable job to assess the fatty liver disease and open doors to welcome new treatment opportunities to deal with the same.

With no real treatment or therapy approved by the U.S. Food and Drug Administration to cure this disease, the new compound is a ray of light, which is believed to have the capacity to deal with the acute problem. In the past, medicines developed to fight liver fibrosis often led to psychiatric side effects as they penetrated the brain and blocked cannabinoid type 1 receptors. New drug developed by the scientists at National Institutes of Health is a massive breakthrough as far as treatment of liver fibrosis. George F Koob, Ph.D., Director, National Institute on Alcohol Abuse and Alcoholism (NIAAA) quoted, “This study represents an important step towards an effective treatment for liver fibrosis.” The newly developed drug has passed the initial screening tests for other side effects such as genotoxicity. However, it will further need safety screenings in animals before turning towards FDA for approval for studies of its therapeutic ability in humans. 

Liver disease affecting Asia-Pacific region

According to Dr. Nalini Prasad Ippela, Head of the Gastroenterology Department in the Ramesh Group of Hospitals, the number of alcohol related liver diseases has shown an upward curve in the state of Andhra Pradesh. The trend is higher in the poor sections of society who opt for cheap and poor quality alcohol. Lower middle class were not far behind. Such a medical condition does not come to notice immediately even if the organ is damaged severely. Thus, the disease is detected very late and by the time people take measures to deal with it, it is pretty late. There are various disorders related to ALD such as fatty liver, alcoholic hepatitis, and chronic hepatitis with liver fibrosis or cirrhosis. FLD is commonly found in individuals who consume large quantities of alcohol. But the bright side is that it is reversible. Once the individual stops consuming alcohol, the condition is reversed. The remedy and cure for ALD is expensive and risky thus it is advised to take good care of your body and regulate the intake of alcohol.

Esteemed scientists returning back to China from premier research centers such as Harvard and MIT are prioritizing research and development for diseases that the Chinese are most expected to be vulnerable to such as liver cancer, chronic hepatitis B, liver fibrosis, and cirrhosis. Frequency of Hepatitis B in China is around 30 times higher than the US. Liver cancer is approximately 11–18 times higher than in Europe and U.S.

The liver disease treatment industry is driven by number of factors. Consumption of alcohol is a major reason why people suffer from liver related diseases. Irregular diet patterns and unhealthy lifestyle contribute to the issue. Thus as more people indulge in the activity, naturally the number of people with liver problems increases. Obesity, metabolic syndrome, diabetes, and cardiovascular disorders are all responsible for the growing rate of diseases that help industry. Government and nonprofit organizations are creating awareness among people and are imparting useful information and data related to it. Scientists and researchers have increased R&D to explore new treatment opportunities and manufacture new medicines that help in curing liver disease. The different types of treatment made available by researchers today are anti-rejection drugs, chemotherapy drugs, targeted therapy, vaccines, anti-viral drugs, immunoglobulins, and corticosteroids.